Antibodies to human CD154

Details for Australian Patent Application No. 2001248350 (hide)

Owner Novartis AG

Inventors Di Padova, Franco E.; Schuler, Walter

Agent Davies Collison Cave

Pub. Number AU-B-2001248350

PCT Pub. Number WO01/68860

Priority 0006398.2 16.03.00 GB

Filing date 14 March 2001

Wipo publication date 24 September 2001

Acceptance publication date 14 October 2004

International Classifications

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

A61P 037/00 Drugs for immunological or allergic disorders

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 October 2004 Application Accepted

  Published as AU-B-2001248350

10 February 2005 Standard Patent Sealed

8 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001248351

2001248349